华盛顿大学医学院临床二期试验:首次证实补充NMN改善糖尿病患者胰岛素敏感性
Click on the blue text above follow GeneChic
原文链接
https://science.sciencemag.org/lookup/doi/10.1126/science.abe9985.DOI: 10.1126/science.abe9985 (2021)
★
参考文献
★
J. Yoshino, J. A. Baur, S. I. Imai, NAD+ intermediates: The biology and therapeutic potential of NMN and NR. Cell Metab. 27, 513–528 (2018).
E. Katsyuba, M. Romani, D. Hofer, J. Auwerx, NAD+ homeostasis in health and disease. Nat Metab 2, 9–31 (2020).
J. Yoshino, K. F. Mills, M. J. Yoon, S. Imai, Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. 14, 528–536 (2011).
M. Razmara, C. H. Heldin, J. Lennartsson, Platelet-derived growth factor-induced Akt phosphorylation requires mTOR/Rictor and phospholipase C-γ1, whereas S6 phosphorylation depends on mTOR/Raptor and phospholipase D. Cell Commun. Signal. 11, 3 (2013).